GILD Gilead Sciences PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: GILD
- PE Ratio
As of May 14, 2025, the Gilead Sciences stock's PE ratio is 20.62. This results from the current EPS of $4.77 and stock price of $98.38. The P/E ratio has a decrease of 93% from the past four quarters average of 296.4.
GILD PE ratio history
The PE ratio of Gilead Sciences has averaged 72.08 over the last ten years. The current PE ratio of 20.62 is 71% below the historical average. Over the past ten years, GILD's PE ratio was at its highest in the Sep 2024 quarter at 838.4, when the stock price was $83.84 and the EPS was $0.1. The lowest value was in the Dec 2016 quarter, when it reached 7.1 with a price of $71.61 and an EPS of $10.08.
Gilead Sciences PE ratio by year
Maximum annual increase: 3,700.39% in 2020
Maximum annual decrease: -97.49% in 2021
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 243.08 | 1,262.56% | $92.37 | $0.38 |
| 2023 | 17.84 | -23.96% | $81.01 | $4.54 |
| 2022 | 23.46 | 60.25% | $85.85 | $3.66 |
| 2021 | 14.64 | -97.49% | $72.61 | $4.96 |
| 2020 | 582.6 | 3,700.39% | $58.26 | $0.1 |
| 2019 | 15.33 | 2.96% | $64.98 | $4.24 |
| 2018 | 14.89 | -26.43% | $62.55 | $4.2 |
| 2017 | 20.24 | 185.07% | $71.64 | $3.54 |
| 2016 | 7.1 | -13.2% | $71.61 | $10.08 |
| 2015 | 8.18 | -31.03% | $101.19 | $12.37 |
| 2014 | 11.86 | -68.25% | $94.26 | $7.95 |
| 2013 | 37.36 | 73.93% | $75.1 | $2.01 |
| 2012 | 21.48 | 89.92% | $36.73 | $1.71 |
| 2011 | 11.31 | 5.5% | $20.47 | $1.81 |
| 2010 | 10.72 | -27.67% | $18.12 | $1.69 |
Gilead Sciences PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 23.49 | -90.34% | $112.05 | $4.77 |
| Dec 2024 | 243.08 | -71.01% | $92.37 | $0.38 |
| Sep 2024 | 838.4 | 938.65% | $83.84 | $0.1 |
| Jun 2024 | 80.72 | -55.92% | $68.61 | $0.85 |
| Mar 2024 | 183.13 | 926.51% | $73.25 | $0.4 |
| Dec 2023 | 17.84 | 12.13% | $81.01 | $4.54 |
| Sep 2023 | 15.91 | -9.4% | $74.94 | $4.71 |
| Jun 2023 | 17.56 | -5.59% | $77.07 | $4.39 |
| Mar 2023 | 18.6 | -20.72% | $82.97 | $4.46 |
| Dec 2022 | 23.46 | 1.56% | $85.85 | $3.66 |
| Sep 2022 | 23.1 | 23.33% | $61.69 | $2.67 |
| Jun 2022 | 18.73 | 13.45% | $61.81 | $3.3 |
| Mar 2022 | 16.51 | 12.77% | $59.45 | $3.6 |
| Dec 2021 | 14.64 | 23.44% | $72.61 | $4.96 |
| Sep 2021 | 11.86 | -29.02% | $69.85 | $5.89 |
GILD Price vs fair value
GILD average PE ratio chart
The current PE ratio of GILD is below the 3, 5 and 10-year averages.
GILD PE vs peers
Compared to its peers LLY and ABBV, GILD's PE ratio stands lower, however it is higher than JNJ's and MRK's. Gilead Sciences's PE ratio is trading below the peer group average of 30.2.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MRK Merck & Co Inc | 10.66 | $184.49B |
| BIIB Biogen Inc | 11.85 | $17.64B |
| PFE Pfizer Inc | 15.84 | $125.19B |
| JNJ Johnson & Johnson | 16.15 | $352.15B |
| GILD Gilead Sciences Inc | 20.62 | $122.38B |
| AMGN Amgen Inc | 23.74 | $141.03B |
| LLY ELI LILLY & Co | 57.99 | $678.16B |
| ABBV AbbVie Inc | 75.19 | $313.43B |
| QGEN Qiagen NV | 95.7 | $8.96B |
| VRTX Vertex Pharmaceuticals Inc | N/A | $108.15B |
| ILMN Illumina Inc | N/A | $12.38B |
Frequently asked questions
What is Gilead Sciences's PE ratio?
GILD stock has a price to earnings ratio of 20.62 as of May 14, 2025.
What is the 3-year average PE ratio for Gilead Sciences (GILD)?
Over the last 3 years, the average price to earnings ratio for GILD stock is 125.34.
What is the 5-year average PE ratio for Gilead Sciences (GILD)?
Over the last 5 years, the average price to earnings ratio for GILD stock is 129.97.
What is the highest PE ratio for GILD?
In the last ten years, the Sep 2024 quarter recorded the highest quarterly PE ratio at 838.4.
How does the current PE ratio for GILD compare to its historical average?
GILD's price to earnings ratio is currently 71% below its 10-year historical average.
How is GILD's PE ratio calculated (Gilead Sciences PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (May 14, 2025), Gilead Sciences's stock price is $98.38. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $4.77. Therefore, Gilead Sciences's P/E ratio for today is 20.62. PE RATIO(20.62) = STOCK PRICE($98.38) / TTM EPS($4.77)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.